Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $85.19B | Healthcare | Pharmaceuticals | United States | NYSE |
| 2 | $84.97B | Healthcare | Pharmaceuticals | United States | NYSE |
| 3 | $51.11B | Healthcare | Pharmaceuticals | United States | NYSE |
| 4 | $41.93B | Healthcare | Pharmaceuticals | United States | NYSE |
| 5 | $33.88B | Healthcare | Pharmaceuticals | United States | NYSE |
| 6 | $31.71B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 7 | $20.25B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 8 | $14.26B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 9 | $9.79B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 10 | $6.59B | Healthcare | Pharmaceuticals | United States | NYSE |
| 11 | $6.40B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 12 | $6.32B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 13 | $5.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 14 | $4.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 15 | $4.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 16 | $3.15B | Healthcare | Pharmaceuticals | United States | NYSE |
| 17 | $2.52B | Healthcare | Pharmaceuticals | United States | NYSE |
| 18 | $1.92B | Healthcare | Pharmaceuticals | United States | NYSE |
| 19 | $1.81B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 20 | $1.35B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 21 | $1.35B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 22 | $1.34B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 23 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 24 | $1.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 25 | $1.18B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 26 | $1.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 27 | $1.12B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 28 | $1.11B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 29 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 30 | $1.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 31 | $1.03B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 32 | $1.03B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 33 | $1.02B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 34 | $1.01B | Healthcare | Pharmaceuticals | United States | NYSE |
| 35 | $999.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 36 | $967.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 37 | $927.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 38 | $903.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 39 | $896.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 40 | $895.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 41 | $841.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 42 | $813.61M | Healthcare | Pharmaceuticals | United States | NYSE |
| 43 | $757.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 44 | $705.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 45 | $702.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 46 | $671.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 47 | $662.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 48 | $654.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 49 | $644.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 50 | $631.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 51 | $629.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 52 | $615.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 53 | $604.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 54 | $597.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 55 | $550.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 56 | $532.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 57 | $525.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 58 | $523.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 59 | $520.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 60 | $503.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 61 | $484.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 62 | $474.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 63 | $468.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 64 | $465.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 65 | $460.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 66 | $453.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 67 | $452.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 68 | $448.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 69 | $448.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 70 | $439.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 71 | $422.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 72 | $422.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 73 | $409.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 74 | $402.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 75 | $398.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 76 | $385.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 77 | $381.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 78 | $366.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 79 | $361.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 80 | $353.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 81 | $348.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 82 | $345.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 83 | $341.40M | Healthcare | Pharmaceuticals | United States | NYSE |
| 84 | $332.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 85 | $324.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 86 | $323.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 87 | $321.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 88 | $311.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 89 | $310.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 90 | $305.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 91 | $286.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 92 | $270.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 93 | $265.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 94 | $262.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 95 | $258.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 96 | $253.86M | Healthcare | Pharmaceuticals | United States | NYSE |
| 97 | $247.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 98 | $247.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 99 | $246.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 100 | $239.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 334 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.